World Health Organization (WHO), Kaduna State Office, Kaduna, Nigeria.
Department of Pharmacology and Toxicology, National Institute for Pharmaceutical Research and Development, Abuja, Nigeria.
Pan Afr Med J. 2021 Dec 30;40:268. doi: 10.11604/pamj.2021.40.268.26961. eCollection 2021.
Adverse Events Following Immunization (AEFI) are one of the main reasons for inadequate immunization coverage in Kaduna State, and AEFI underreporting serves as a barrier to achieving goals of global pharmaco-vigilance for vaccine. The purpose of this study is to estimate the completeness of variables in the AEFI line-listing forms, calculate AEFI reporting rates by Local Government Areas & vaccine type and profile the reported cases according to their reactions.
we conducted a descriptive, cross-sectional, retrospective study of primary surveillance records. We calculated AEFI reporting rates in the State and Local Government areas and AEFI Vaccine reaction rates to the various antigens. We used Binary logistic regression to determine the association between gender and vaccine reactions.
seven thousand eight hundred and twenty-four (7,824) AEFI cases were reported. The completeness of variables on the filled AEFI line-list varied from 21% to 100%. The State had a high AEFI reporting rate of 9.09 per 10,000 administered doses. Fever (<38oC) was the main AEFI reaction. Severe AEFI cases accounted for only 0.89% of the total reported cases. Pentavalent vaccine was the suspect antigen responsible for the highest number of AEFI cases, with a vaccine reaction rate of 44.77 per 10,000 doses. The Zaria Local Government area had the highest AEFI reporting rate, while the Sanga Local Government area had the lowest AEFI reporting rate in the State. The difference between genders in the number of reported AEFI cases was not statistically significant (p>0.05). There were 35% higher odds of occurrence of bleeding among males than among females (aOR: 1.354; P-value: p=.012; 95% CI: 1.070-1.715; Nagelkerke-R: 0.003). The other reactions were not significantly related to gender.
our study shows a higher occurrence of severe AEFI in subjects undergoing pentavalent vaccine. Thiscaused the highest incidence of AEFI. There was no significant association between gender and AEFI reactions.
接种后不良反应(AEFI)是导致卡杜纳州免疫接种覆盖率不足的主要原因之一,AEFI 漏报是实现疫苗全球药物警戒目标的障碍。本研究旨在评估 AEFI 列表形式中变量的完整性,按地方政府区和疫苗类型计算 AEFI 报告率,并根据反应对报告病例进行分析。
我们对初级监测记录进行了描述性、横断面、回顾性研究。我们计算了该州和地方政府区的 AEFI 报告率和各种抗原的 AEFI 疫苗反应率。我们使用二项逻辑回归来确定性别与疫苗反应之间的关系。
共报告了 7824 例 AEFI 病例。填写的 AEFI 列表中的变量完整性从 21%到 100%不等。该州的 AEFI 报告率很高,每 10000 剂接种 9.09 例。发热(<38°C)是主要的 AEFI 反应。严重 AEFI 病例仅占报告病例总数的 0.89%。五联疫苗是导致 AEFI 病例最多的可疑抗原,每 10000 剂疫苗的反应率为 44.77。扎里亚地方政府区的 AEFI 报告率最高,而该州桑加地方政府区的 AEFI 报告率最低。报告的 AEFI 病例数量在性别之间没有统计学差异(p>0.05)。与女性相比,男性发生出血的可能性高 35%(优势比:1.354;P 值:p=0.012;95%CI:1.070-1.715;Nagelkerke-R:0.003)。其他反应与性别无显著关系。
我们的研究表明,接受五联疫苗的受试者中严重 AEFI 的发生率更高。这导致 AEFI 发生率最高。性别与 AEFI 反应之间没有显著关系。